CRISPR Therapeutics News

CRISPR Therapeutics | 8-K: CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

May 8 15:22

CRISPR Therapeutics | DEF 14A: Definitive information statements

Apr 9 15:47

CRISPR Therapeutics | DEFA14A: Others

Apr 9 15:46

CRISPR Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Mar 27 15:36

CRISPR Therapeutics | 8-K: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 21 06:50

CRISPR Therapeutics | 8-K: Current report

Feb 13 21:28

CRISPR Therapeutics | 8-K: Current report

Feb 13 05:34

CRISPR Therapeutics | 8-K: Current report

Jan 15 23:00

CRISPR Therapeutics | 8-K: Current report

Dec 19, 2023 15:23

CRISPR Therapeutics | 8-K: Current report

Dec 15, 2023 07:58

CRISPR Therapeutics | 8-K: Current report

Dec 13, 2023 08:22

CRISPR Therapeutics | 8-K: Current report

Dec 8, 2023 12:16

CRISPR Therapeutics | 8-K: Current report

Dec 4, 2023 15:26

CRISPR Therapeutics | 8-K: Current report

Nov 16, 2023 06:21

CRISPR Therapeutics | 8-K: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results

Nov 6, 2023 15:33

CRISPR Therapeutics | 8-K: Current report

Sep 7, 2023 07:39

CRISPR Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 7, 2023 15:18

CRISPR Therapeutics | 8-K: Current report

Aug 7, 2023 15:07

CRISPR Therapeutics | 8-K: Current report

Jun 9, 2023 15:29

CRISPR Therapeutics | 8-K: Current report

Jun 9, 2023 06:07